Fidelity
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

ONVO RSS Feed
Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, chaostrader, bfsingle
Search This Board:
Last Post: 4/16/2014 4:35:37 PM - Followers: 258 - Board type: Free - Posts Today: 0
                                 

ONVO

on

NYSE EXCHANGE NOW




Thu, Jul 11, 2013 12:00 - Organovo Holdings, Inc. (ONVO: NYSE Amex) - Venue Change - The symbol, ONVO, no longer trades on OTC Link. As of Thu, Jul 11, 2013, ONVO trades on NYSE Amex. You may find a complete list of venue changes at otcmarkets.com.

 
 
     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


 
ONVO Security Details Share Structure
Market Value
$242,497,488 a/o Jun 5, 2012
Shares Outstanding 43,693,241 a/o Mar 16, 2012

Float Not Available
Authorized Shares 150,000,000 a/o Feb 03, 2012


IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com


Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994


For all the latest company information, details, news, please visit http://www.organovo.com






 
Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:



Science

Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.

                                                                                                                          




World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

   Organovo Support Chart


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.
 

                                                                                                                                                         


PostSubject
#1136  Sticky Note Imaging You tube video about ONVO. Must watch. Badali 07/10/13 02:24:04 PM
#5682   2 after hour trades. 100k and 25k. Loco Motion 04/16/14 04:35:37 PM
#5681   Wish I had held those $7 calls now! risk on 04/16/14 03:43:31 PM
#5680   Wow, strength ! risk on 04/16/14 01:06:37 PM
#5679   I hope they ignore them and get to Windbag1014 04/16/14 12:53:26 PM
#5678   I would hope that ONVO can take legal 72vett 04/16/14 12:48:58 PM
#5677   Interesting Article About Oganovo Shorts: rookiecrd1 04/16/14 09:36:21 AM
#5676   I think that there are still a few poorman1 04/16/14 08:02:53 AM
#5675   I think now that the rat is out RandolRocketman 04/16/14 12:09:38 AM
#5674   Shnikeys, you gotta watch this stock like a bg1641 04/15/14 05:09:10 PM
#5673   Look at this strength! HS, got a harami risk on 04/15/14 02:57:43 PM
#5672   Wasn't me man that's for sure, probably Tislon adeezl 04/15/14 02:23:31 PM
#5671   Wow, wtf was that?! Huge drop $6 may risk on 04/15/14 02:20:39 PM
#5670   SLAAAAM - haha.. that's how it's done, who adeezl 04/15/14 02:19:24 PM
#5669   I'd say shorts know there's really no need adeezl 04/15/14 02:11:06 PM
#5668   That was certainly a very sustained short attack RandolRocketman 04/15/14 02:07:05 PM
#5667   I don't know enough about fundamentals to post risk on 04/15/14 02:03:31 PM
#5666   Playing this on either side equals trying to adeezl 04/15/14 02:01:52 PM
#5665   Nice turn on $6 risk on 04/15/14 01:59:57 PM
#5664   Yeah, I don't know about that, I trade. risk on 04/15/14 01:56:42 PM
#5663   Who's trying? Do you even read? I don't risk on 04/15/14 01:50:23 PM
#5662   Still trying I see, when will folks realize adeezl 04/15/14 01:48:08 PM
#5661   Why? Did it burn you today? Loco Motion 04/15/14 01:47:37 PM
#5660   Me and John Boehner want to know , BornAtNight 04/15/14 01:03:38 PM
#5659   or FIND & PROSECUTE the FUDsters for damage grantg2 04/15/14 11:56:07 AM
#5658   Gap fills are just understood , and yes, risk on 04/15/14 11:22:29 AM
#5657   Nice upmove to start the day - but doglover1 04/15/14 10:34:36 AM
#5656   They need to stop commenting on this stuff. risk on 04/15/14 09:05:27 AM
#5655   Sold in premarket for quick gain 3DPrintInvestor 04/15/14 09:00:19 AM
#5654   Organovo Comments on Misleading and Inaccurate Reports 72vett 04/15/14 08:10:03 AM
#5653   It's the big money positioning itself for the dabonenose 04/14/14 10:26:15 PM
#5652   BINGO! We have a winner! :-D hotrod34racer 04/14/14 10:12:02 PM
#5651   if you go to the organovo website you 2014trader 04/14/14 06:29:42 PM
#5650   Any others upcoming that is planned? Can you deanmichelson 04/14/14 06:15:34 PM
#5649   Hope so. I should've sold when Keith anarmyofme 04/14/14 05:46:23 PM
#5648   First commercial product in December- 3D liver assay 3DPrintInvestor 04/14/14 05:45:33 PM
#5647   So this is essentially all speculation and hopeful? deanmichelson 04/14/14 05:33:50 PM
#5646   Can anyone update me as to why there deanmichelson 04/14/14 05:21:34 PM
#5645   Got some 6.35 today. 3DPrintInvestor 04/14/14 05:18:38 PM
#5644   Looks like it may have agreed to stop risk on 04/14/14 03:46:53 PM
#5643   Congratulations - AND, ....I'm jealous. doglover1 04/14/14 03:44:49 PM
#5642   Nope, if you want to make money, trade. risk on 04/14/14 03:43:31 PM
#5641   All symbols have a " story" . Charts risk on 04/14/14 03:40:30 PM
#5640   Charts work really well for big banks and doglover1 04/14/14 03:38:55 PM
#5639   Added 20k dshade 04/14/14 03:38:01 PM
#5638   It not just ONVO manfromjax 04/14/14 03:33:13 PM
#5637   "Sell in May and go away." Jim Rogers doglover1 04/14/14 03:31:15 PM
#5636   So I guess the moral of the story Homertoeclipper1 04/14/14 03:30:30 PM
#5635   It's going to not get there, at least risk on 04/14/14 03:27:36 PM
#5634   Went thru your support zone. Let's hope my doglover1 04/14/14 03:25:27 PM
#5633   8.6 >>>>>>>6.15, ( 3 days) BRUTAL risk on 04/14/14 03:22:05 PM
PostSubject